Issue Date | Title | Involved Person(s) |
2022 | Infliximab reference product versus biosimilar for the treatment of rheumatoid arthritis | Mattli, Renato; Grobet, Cécile; Sharakin, Maxim; Pöhlmann, Johannes; Vinci, Linda, et al |
2020 | Infliximab reference product versus biosimilar for the treatment of rheumatoid arthritis : scoping report | Pöhlmann, Johannes; Mattli, Renato; Syleouni, Maria-Eleni; Carlander, Maria Johanna; Meier, Flurina, et al |